Hub Research Capacity Participant & Clinical Interactions

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
How To Impact Your Research: An Overview of Research Support Services Quincy J. Byrdsong, Terri Hagan, and Alice Owens-Gatlin Research Services Consultants.
UC BRAID: Co-creating and evaluating performance in a regional laboratory for conducting translational science UC BRAID Executive Committee: Steven Dubinett.
Institute of Medicine Report:
Nursing Research Opportunities in the USPHS CAPT. Victoria L. Anderson, RN, CRNP, MSN.
Department of Biostatistics Growth and Finance. Department as of December faculty (not including secondary and adjunct appointments) – 20 Tenured.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
SARC Submission Process NIH Sponsored Studies Cooperative Group/Pilot Foundation Sponsored Studies Investigator Initiated Industry Studies Pat Kittelson.
Vanderbilt Institute for Clinical and Translational Research (VICTR) VICTR Application and Review Process.
New Faculty Orientation September 21, 2010 Mark Stacy, MD Associate Dean of Clinical Research Professor of Neurology Site Based Research at Duke.
Center for Health Care Quality Licensing & Certification Program Evaluation 1 August 2014 rev.
Administrative Officer DutiesAndResponsibilities A mountain of paper.
The Office of Research, Health Sciences
Capacity Task Force Virginia Health Reform Initiative January 14, 2011
Ron Sokol, M.D. Principal Investigator, CCTSI Bonnie Walters Executive Director, The Evaluation Center Kathryn Nearing, Ph.D. Associate Director, The Evaluation.
Overview: FY12 Strategic Communications Plan Meredith Fisher Director, Administration and Communication.
OnCore Roll Out April 8, 2011.
Tufts Clinical and Translational Science Institute.
Responsible Conduct of Research (RCR) What is RCR? New Requirements for RCR Who Does it Affect? When? Data Management What is the Institutional Plan? What.
CCR Clinical Research Priorities Clinical research is an essential part of the CCR research program Translational (collaborative) Interaction between basic.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
VICTR Funding Overview Vanderbilt Institute for Clinical and Translational Research (VICTR) June 22, 2012.
The Need for Training on Team and Meeting Management to Enhance Capacity for Team Science Kady Nearing, Senior Evaluator The Evaluation Center Colorado.
RESIDENT PROJECTS ROBERT LEONHARD QUALITY IMPROVEMENT MANAGER.
1 ACLA: An Overview and 2010 Proposed Budget. Topics to be Covered Overview of ACLA Program Services Outreach Services 2009 Focus 2010 Agenda and Budget.
Item 5d Texas RE 2011 Budget Assumptions April 19, Texas RE Preliminary Budget Assumptions Board of Directors and Advisory Committee April 19,
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
Building a Research Core Road Map and Lessons Learned Scott A. LeMaire, MD Professor of Surgery and of Molecular Physiology and Biophysics Vice Chair for.
August 20, 2008 Clinical and Translational Science Awards (CTSA) CTSA Evaluation Approach Institute for Clinical & Translational Research (ICTR)
KEYS TO SUCCESS NCURA Region IV Spring Meeting April 27 – 30, 2014 © 2014 National Council of University Research Administrators Managing Faculty Appointments.
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Clinical Research Services: “The Beat Goes On” CTSI.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Sharing Resources: Best Practices to Turn NICL into Gold Katia Sol-Church, PhD Director Biomolecular Core Laboratory at Nemours Research Associate Professor.
Data Coordinating Center University of Washington Department of Biostatistics Elizabeth Brown, ScD Siiri Bennett, MD.
OVERVIEW OF THE WORKFORCE DEVELOPMENT DOMAIN TASK FORCE APRIL 16, 2015 Joan D. Nagel, M.D., M.P.H. Program Director, Division of Clinical Innovation National.
Assistant Vice Chancellor for Clinical and Translational Science
Sustainable Entity Update #2 Discussion Document
Job Titles Examples Used for HISD Nonexempt Jobs
Workforce Development Domain Task Force
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Case Costing at TBRHSC June 2015.
Clinical Learning Environment Review GMEC January 8, 2013
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
The Essentia Institute of Rural Health (EIRH) is
University Career Services Committee
Clinical Trial Budgeting
NIH Clinical Trial Requirements
TRI Resources for Researchers
Jennifer S. Novia INFO 643 March 6, 2011
REDCap Regulatory Binder
Centralization and Standardization Listening Session
RECOGNITION OF CLINICAL TRIAL CANCER RESEARCH
Department of Medicine Michael Farkouh, Vice-Chair Research michael
Professional development and resources for clinical trial management
Johns Hopkins Medicine Innovation 2023 Strategic Plan
An Investigator’s Guide to the Clinical and Translational Science Awards and the Trial Innovation Network (TIN)  What can we do for you? May 2017.
Clinical and Translational Science Awards Program
Quality and Process Improvement Program (QPIP)
Research Studio Program
Hub Research Capacity Integrating Special Populations
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Jennifer Esala, Ph.D. Evaluation Core Director
Research Methods - Regulatory Knowledge and Support
Presentation transcript:

Hub Research Capacity Participant & Clinical Interactions Wendy M Kohrt, PhD Associate Director

CCTSI Organizational Structure

PCI Specific Aims 2018-2023 Aim 4. Implement OnCore to manage and track all human subject protocols with more than minimal risk 4.1 Centralize management of protocol documents for coordinated reviews by the Scientific Advisory and Review Committee (SARC), Colorado Multiple Institutional Review Board (COMIRB), and other entities 4.2 Assess protocol resource needs and feasibility through the standardized development of the protocol calendar of events and budget

PCI Specific Aims 2018-2023 Aim 5. Develop the PCI Management Program that will provide oversight of centralized clinical research facilities and expand resources to improve the quality, efficiency, and safety of clinical research 5.1 Promote the use of centralized research facilities staffed by trained research nurses and technicians and expand mobile research capabilities within CHCO and UCH 5.2 Manage specialized clinical research resources that require unique facilities, equipment, and/or trained personnel to ensure the quality of data collection and efficiency and safety of operation 5.3 Expand the pool of centrally-managed research/trials personnel under a fee-for-service model, including research coordinators, budget specialists, and regulatory specialists

PCI Specific Aims 2018-2023 Aim 6. Ensure the high quality and scientific impact of the clinical research portfolio through rigorous review of scientific merit, monitoring of protocol benchmarks of success, and tracking of dissemination of results 6.1 Ensure high scientific merit of all protocols involving more than minimal risk to human subjects through peer review by SARC, populated by investigators from the CCTSI affiliates with broad scientific expertise 6.2 Utilize OnCore to monitor protocol-specific benchmarks of success (participant accrual/retention, adherence to the protocol, safety) and ClinicalTrials.gov to monitor updates and dissemination of results

Accomplishments Aim 4 Implement OnCore to manage and track human subject protocols Gradual changes have been adopted to move toward centralized management of protocol documents for coordinated protocol reviews by multiple entities New adult clinical protocols are now required to use OnCore and develop calendars of events and budgets for all services provided through the CTRC Network and hospitals CHCO is in the processing of changing to OnCore as the CRMS – all new protocols using OnCore – Jan. 2019

Accomplishments Aim 5 Develop the PCI Management Program that will provide centralized clinical research facilities and expand resources to improve the quality, efficiency, and safety of clinical research UCH and CHCO CTRCs each added 1.0 FTE of nursing support to increase mobile services and expand the availability of clinical research support. Installed Harvard Scheduler to streamline CTRC scheduling; a 1.0 FTE Scheduler Manager was hired and a 1.0 FTE General Scheduler will be hired. The Clinical Research Support Team (CReST; launched in April 2017) at UCH added 2 research coordinators (total of 6) and 1 on-site study monitor (new position); CReST supports 109 adult protocols from 15 departments and divisions. CHCO (Research Institute) has a separate pool of research coordinators (n=60), budget specialists, and regulatory specialists that are available to support pediatric protocols.

Accomplishments Aim 6 Ensure the high quality and scientific impact of clinical research through rigorous review of scientific merit, monitoring of protocol benchmarks of success, and tracking of dissemination of results SARC reviews all clinical research protocols at CU-AMC (and all CU-Boulder and NJH CTRC protocols) for scientific merit and helps junior investigators design high quality protocols. Initiated a new policy to engage all recipients of CTRC MicroGrants in SARC protocol reviews under the guidance of a SARC Chair. This approach increases the number of reviewers, provides training in grant review, and increases the breadth of expertise on SARC. Have not yet started using OnCore to monitor protocol-specific benchmarks of success (participant accrual/retention, adherence to the protocol, safety)

CTRC Active Protocols

New Protocols

CTRC Outpatient Visits

CTRC Inpatient Days and Visits

Oxygen Saturation (SpO2) Swan-Ganz catheter Transcranial Doppler Gas Exchange (VO2) BP by arterial line Oxygen Saturation (SpO2)

Core Lab Assays

Protocols Supported by Core Labs

Nutrition Core Activity

CTRC Revenue % values are percent of operating costs

Clinical Research Support Team

MicroGrants Program UCH CHCO Budget Awarded Spent Awards # Y1 $150,000   UCH CHCO Budget Awarded Spent Awards # Y1 $150,000 $79,968 $8,947 6 $300,000 $28,167 $1,128 2 Y2 $175,000 $470,276 $35,957 24 $182,704 $41,294 14 Y3 $200,000 $164,000 $253,593 12 $121,500 $66,761 13 Y4 $225,000 $168,300 $230,284 10 $168,700 $67,765 Y5 $250,000 $225,700 $135,215 $217,700 $207,385 Y6 $177,000 $126,050 9 $204,000 $45,206 Total $1.25M $1.29M $0.8M 75 $1.75M $0.9M $0.4M 61

CTRC User Satisfaction

CTRC User Satisfaction

CTRC User Satisfaction

CTRC User Satisfaction

CTRC User Satisfaction

CTRC User Satisfaction

PCI Governance Structure Director Wendy Kohrt Director of Operations Janine Higgins CTRC Administrator Pamila Allen UCH CTRC Medical Director Thomas Campbell Nurse Manager Diane Branham Perinatal CTRC Medical Director Chris Baker Nurse Manager Lisa Lewis NJH CTRC Medical Director Donald Leung Nurse Manager Susan Leung CHCO CTRC Medical Director Philip Zeitler Nurse Manager Lisa Lewis CU-B CTRC Medical Director Brian Stauffer Nurse Manager Debra Cody

National CTSA Consortium Involvement Participation in CTSA Consortium Working Groups Higgins, Lockie, Proctor – Common Metrics Initiative Kohrt – Methods & Processes DTF Hammack – GCP training CTSA-related collaborations Kohrt – UC Irvine Institute for Clinical and Translational Science Clinical Research Expert Committee for Terminology Harmonization in Exercise Medicine and Science (THEMES) MoTrPAC – NIH Common Fund initiative on Molecular Transducers of Physical Activity Consortium; utilizing Trial Innovation Network for single IRB; Colorado is a Clinical Center

Response to EAC Critiques “Metrics for success might include a balanced scorecard of academic productivity, finance and satisfaction of faculty, staff and research participants. A difficult question is whether the metrics should be kept on all studies or only those that touch the CCTSI.” Currently, these metrics are requested only from CCTSI members and participants in projects conducted on the CTRCs.

Response to EAC Critiques “One issue is capacity planning for study coordinators hired centrally. Management requires focus on both professionalism (promotions and salary) and an effort allocation system that promotes sharing of coordinator effort across projects.” CReST expansion space in current (and future) facilities is limited; leadership is aware of the situation Career advancement guidelines are in development Effort certification is completed through iLabs to capture activity on multiple projects In 2 years of operation, CReST has never turned down a request for service, including coverage for gaps or transitions in support, and can support a full range of services (project coordination, budget development, regulatory oversight, etc.)

Questions for EAC Research teams are complaining about duplication of effort with the use of OnCore. Some information recorded in OnCore must also be recorded in Epic, study-specific CRFs for the sponsor, and/or the research database. Do your institutions require that investigators use a CTMS? Are there any carrots to encourage (or sticks to discourage) participation? Do your institutions use a CTMS to identify struggling studies? If yes, does the CTSA provide study-specific rescue plans?